Nwi Management LP Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Nwi Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$99.73 - $148.48 $4.99 Million - $7.42 Million	-50,000 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$65.07 - $98.24 $6.18 Million - $9.33 Million	-95,000 Reduced 65.52%	50,000 $4.29 Million
Q3 2020 Nov 16, 2020	SELL	$59.04 - $77.95 $15.1 Million - $19.9 Million	-255,000 Reduced 63.75%	145,000 $9.43 Million
Q1 2020 May 13, 2020	BUY	$27.51 - $57.29 $5.5 Million - $11.5 Million	200,000 Added 100.0%	400,000 $13.6 Million
Q3 2019 Nov 14, 2019	BUY	$37.38 - $49.47 $7.48 Million - $9.89 Million	200,000 New	200,000 $8.34 Million

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Nwi Management LP, based on Form 13F filings with the SEC.

Stay updated on Nwi Management LP with notifications on news.